DE69619259T2 - Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase - Google Patents

Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase

Info

Publication number
DE69619259T2
DE69619259T2 DE69619259T DE69619259T DE69619259T2 DE 69619259 T2 DE69619259 T2 DE 69619259T2 DE 69619259 T DE69619259 T DE 69619259T DE 69619259 T DE69619259 T DE 69619259T DE 69619259 T2 DE69619259 T2 DE 69619259T2
Authority
DE
Germany
Prior art keywords
isothiourine
amidine
inhibitors
derivatives
nitrogen oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69619259T
Other languages
English (en)
Other versions
DE69619259D1 (de
Inventor
James Macdonald
James Matz
William Shakespeare
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9600275A external-priority patent/SE9600275D0/xx
Priority claimed from SE9603300A external-priority patent/SE9603300D0/xx
Priority claimed from SE9603301A external-priority patent/SE9603301D0/xx
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE69619259D1 publication Critical patent/DE69619259D1/de
Publication of DE69619259T2 publication Critical patent/DE69619259T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treating Waste Gases (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Gas Separation By Absorption (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE69619259T 1995-11-07 1996-11-06 Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase Expired - Fee Related DE69619259T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US625395P 1995-11-07 1995-11-07
US627695P 1995-11-07 1995-11-07
SE9600275A SE9600275D0 (sv) 1996-01-25 1996-01-25 Compounds
SE9603300A SE9603300D0 (sv) 1996-09-11 1996-09-11 Compounds
SE9603301A SE9603301D0 (sv) 1996-09-11 1996-09-11 Compounds and compositions
PCT/SE1996/001425 WO1997017344A1 (en) 1995-11-07 1996-11-06 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase

Publications (2)

Publication Number Publication Date
DE69619259D1 DE69619259D1 (de) 2002-03-21
DE69619259T2 true DE69619259T2 (de) 2002-09-19

Family

ID=27532790

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69619259T Expired - Fee Related DE69619259T2 (de) 1995-11-07 1996-11-06 Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase

Country Status (24)

Country Link
EP (1) EP0861250B1 (de)
JP (1) JP2000500132A (de)
KR (1) KR19990067349A (de)
AT (1) ATE213241T1 (de)
AU (1) AU701329B2 (de)
BR (1) BR9611276A (de)
CA (1) CA2235301A1 (de)
CZ (1) CZ139298A3 (de)
DE (1) DE69619259T2 (de)
DK (1) DK0861250T3 (de)
EE (1) EE9800141A (de)
ES (1) ES2171743T3 (de)
HU (1) HUP9900142A3 (de)
IL (1) IL124296A0 (de)
IS (1) IS4725A (de)
NO (1) NO982072L (de)
NZ (1) NZ322227A (de)
PL (1) PL326554A1 (de)
PT (1) PT861250E (de)
SI (1) SI0861250T1 (de)
SK (1) SK61098A3 (de)
TR (1) TR199800813T2 (de)
TW (1) TW458978B (de)
WO (1) WO1997017344A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4947197A (en) * 1996-10-16 1998-05-11 Glaxo Group Limited Tetrahydro-6h-pyrazino{1,2-b}isoquinoline 1,4-diones as apoprotein b-100 inhibitors
SE9701681D0 (sv) 1997-05-05 1997-05-05 Astra Ab New compounds
SE9901901D0 (sv) * 1999-05-26 1999-05-26 Astra Ab Compounds
US7384957B2 (en) 2001-12-19 2008-06-10 H. Lundbeck A/S 3,4-dihydro-1H-isoquinolin-2-yl-derivatives
US6608193B2 (en) * 2001-12-21 2003-08-19 The Procter & Gamble Company Methods for synthesis of amino-tetrahydroisoquinoline ring compounds
DK1539724T3 (da) * 2002-08-07 2008-02-11 Neuraxon Inc Aminobenzothiazolforbindelser med NOS-inhiberende aktivitet
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
JP2009501705A (ja) * 2005-07-05 2009-01-22 アストラゼネカ・アクチエボラーグ 新規化合物、その製造方法、中間体、医薬組成物、並びにアルツハイマー病、認知障害、統合失調症に伴う認識機能障害、肥満及びパーキンソン病のような５−ｈｔ６介在疾患の治療におけるそれらの使用
JP5497429B2 (ja) 2007-03-07 2014-05-21 武田薬品工業株式会社 ベンゾオキサゼピン誘導体およびその用途
BR112019012782A2 (pt) 2016-12-23 2020-03-31 Daiichi Sankyo Company, Limited Composto, composição farmacêutica, inibidor de tnap, uso de um composto, e, método para tratamento ou profilaxia de uma doença ou condição e para inibir tnap em um indivíduo.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009619A2 (en) * 1993-10-04 1995-04-13 The Wellcome Foundation Limited Substituted urea and isothiourea derivatives as no synthase inhibitors
AU6286294A (en) * 1993-03-23 1994-10-11 Astra Aktiebolag Guanidine derivatives useful in therapy
US5807885A (en) * 1993-08-12 1998-09-15 Astra Aktiebolag Amidine derivatives with nitric oxide synthetase activities
TW397812B (en) * 1995-02-11 2000-07-11 Astra Ab Bicyclic isothiourea derivatives useful in therapy

Also Published As

Publication number Publication date
HUP9900142A2 (hu) 1999-05-28
EP0861250A1 (de) 1998-09-02
DK0861250T3 (da) 2002-04-29
SI0861250T1 (en) 2002-06-30
TW458978B (en) 2001-10-11
JP2000500132A (ja) 2000-01-11
DE69619259D1 (de) 2002-03-21
IL124296A0 (en) 1998-12-06
PL326554A1 (en) 1998-09-28
ATE213241T1 (de) 2002-02-15
BR9611276A (pt) 1999-01-26
ES2171743T3 (es) 2002-09-16
IS4725A (is) 1998-04-24
MX9803453A (es) 1998-09-30
CZ139298A3 (cs) 1998-09-16
KR19990067349A (ko) 1999-08-16
CA2235301A1 (en) 1997-05-15
PT861250E (pt) 2002-07-31
EP0861250B1 (de) 2002-02-13
EE9800141A (et) 1998-10-15
SK61098A3 (en) 1999-01-11
NO982072L (no) 1998-07-03
TR199800813T2 (xx) 1998-07-21
HUP9900142A3 (en) 2001-08-28
NZ322227A (en) 1999-11-29
AU7592796A (en) 1997-05-29
NO982072D0 (no) 1998-05-06
WO1997017344A1 (en) 1997-05-15
AU701329B2 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
DE69618231D1 (de) TETRAHYDROIMIDAZOPYRIDOINDOLDIONE ALS cGMP SPEZIFISCHE PDE HEMMER
SE0202463D0 (sv) Novel compounds
HK1089163A1 (en) Quinoxaline derivatives as neutrophil elastase inhibitors and their use
DK0657458T3 (da) Inhibitorer af proteinkinase-C
SE0302487D0 (sv) Novel compounds
CO5031285A1 (es) Triarilimidazoles
NO996108L (no) 9-oksinerytromycinderivater
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
SE0302323D0 (sv) Novel compounds
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
NO984470L (no) Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
DE69619259D1 (de) Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase
NO20001198L (no) Pyrrolopyrrolondervater som inhibitorer av nøytrofil elastase
DE69330601T2 (de) Serotoninergische ergolin derivate
SE0202461D0 (sv) Novel compounds
MXPA99009882A (es) Derivados de amidina como inhibidores de la oxidonitrico sintasa.
SE9901901D0 (sv) Compounds
SE9904676D0 (sv) Novel compounds
SE9904677D0 (sv) Novel compounds
SE0000477D0 (sv) Novel compounds
SE9603284D0 (sv) New compounds
SE9802650D0 (sv) Compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee